He & She MD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.3/10
Best for: buyers ready to prepay a year to get compounded semaglutide at $99 a month
He & She MD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on ease of signing up. Its compounded semaglutide costs $99 a month, paid up front, 50% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Prices checked October 2026
He & She MD sells compounded semaglutide and tirzepatide injections only on 3-, 6- and 12-month plans paid up front. Semaglutide runs $447 for three months ($149 a month) down to $1,188 a year ($99 a month); tirzepatide runs $627 ($209) to $1,908 a year ($159). Oral versions and brand Ozempic, Zepbound and Wegovy access are also listed. Care comes from Wasef Health, PC, and GLP-1s ship to every state except Louisiana.
Is He & She MD legit?
Yes. He & She MD is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 8.3/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
See how He & She MD compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to He & She MD
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Found
Best for: people who want clinician visits billed to commercial insurance, with compounded medication in the plan price
Editorial score · methodology
He & She MD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- 49 states + DC
- FDA status
- No FDA warning letters found
How He & She MD scores
Six columns, each one computed from something He & She MD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.0/10$99/month is 50% below the $199 median for compounded semaglutide across the sellers we compare. Every listed price requires paying for several months up front, so Value is capped at 6.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
8.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.8/10Serves 49 of 50 states and DC.
Support10%
8.5/10The price covers the medication, clinician visits, shipping and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on He & She MD
Last checked October 2026- Checked the listed price across 8 dose or plan tiers
- Checked state coverage: 49 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for He & She MD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with He & She MD involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1He & She MD shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask He & She MD which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits, shipping and coaching.
- Lowest ongoing monthly price: semaglutide $99, tirzepatide $159. That leaves out membership fees, first-month rates and insurance copays.
- He & She MD serves 49 of 50 states and DC, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting He & She MD
- He & She MD offers email support
Cancelling He & She MD
Taken from the terms He & She MD publishes. Terms change, so check the current policy before you subscribe.
- Minimum commitment
- 3, 6 or 12 months, paid up front
- Refund policy
- Only charged if prescribed
Medications He & She MD lists
He & She MD lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
"Pay $447 every 3 months". Medication, supplies, shipping, provider support and messaging included.
"Pay $834 every 6 months".
"Pay $1,188 annually"; the site's "GLP-1 for $99/mo" headline is this plan.
"Pay $627 every 3 months".
"Pay $1,194 every 6 months".
"Pay $1,908 annually".
Homepage card "$239 $209/mo to start"; its footnote still describes an older $199 six-month offer renewing at $239.
Homepage card "$299 $269/mo to start".
Check the price yourself before you pay
Every figure here comes from He & She MD's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $99 a month, 50% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $159 a month, 41% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves 49 states and DC
- We found no FDA warning letters issued to He & She MD
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
He & She MD: a low-entry GLP-1 program that lets you pick your format
One flexible product line, the GLP-1 Platinum program, is what this nationwide cash-pay telehealth clinic is built around. Several ways in exist, and that, rather than one rock-bottom number, is what earns the clinic a look: injectable semaglutide and tirzepatide both sell on a six-month introductory rate that steps up afterward, and an oral pill version exists for anyone who would rather avoid needles. Buying a full year up front drops the monthly figure further still. Entry pricing on that scale sits beneath the $167 category median, in a market where the dearest tenth of compounded sellers charges about three times the cheapest tenth. Nothing is charged to you unless a clinician does in fact write a prescription. For everyday patients who want to try tirzepatide, or semaglutide, without committing to a high monthly outlay up front, that is a genuinely approachable on-ramp.
What the headline prices leave out
Understand this before signing up: the headline prices are introductory rates tied to a subscription term, not the long-run cost. The injectable plan advertises its low intro price on a six-month commitment and then steps up to a higher standard monthly rate afterward. The oral tier follows the same pattern at a somewhat higher level. The lowest figure the clinic advertises is not an introductory rate at all: it is the price of buying twelve months of injectable semaglutide in one go, divided by twelve. That is the longest commitment on offer, not the easiest way in. None of this is a teaser-then-cancel trap exactly, but they are teaser rates, so budget for the post-intro price rather than the sticker on the homepage. Before you choose the twelve-month prepay, read the terms you agree to at checkout.
- Twelve-month prepay: the lowest per-month figure advertised, and the largest sum committed up front
- Standard injectable: the mainstream choice, intro-priced over a six-month plan
- Oral option: a needle-free route at a modest premium over the injectable
- Billing safeguard: nothing is billed until a prescription is written for you, and no add-on fees hide behind the rate
The medications and who fills them
Transparency is this clinic's strongest suit, and the pharmacy disclosure is why. Two FDA-registered compounders are named outright: Specialty Medical Drugstore LLC, trading as GoGoMeds, and F&F Pharmacies Inc, which operates Jungle Jims Pharmacy out of Fairfield, Ohio. Plenty of competitors never say who compounds their product; naming them puts the supply chain within your reach to check. The catalog itself runs to tirzepatide and semaglutide, compounded, as injections or in oral form. The oral form has far less behind it: the approved semaglutide tablet absorbs only about 1% to 2% of its dose, and no human absorption study of sublingual semaglutide drops has been published. Brand-name Zepbound, Wegovy and Ozempic are advertised too, for anyone who wants the FDA-approved finished products.
What you get besides the vial
Fees that other clinics itemize are folded into the Platinum membership. Inside the price: the medication, the clinician consultation, expedited shipping at no extra cost, coaching built around GLP-1 use with nutrition guidance, and progress tracking in the app. Clinician access is billed as unlimited. In practice that means no rationing of messages and no per-follow-up charge when a dose needs adjusting or a side effect worries you. If what you want is a prescription in the mail and nothing else, that support is dead weight. If this is your first GLP-1 and you want someone to talk to, it is a real part of what you are paying for.
Coverage and the fine print
Delivery reaches DC and 49 states. Louisiana is the single hard exclusion. PO boxes are refused everywhere, so have a street address ready. Billing is cash-pay: no insurance claim is filed on your behalf and the cost comes out of pocket. Compounded-GLP-1 telehealth works this way almost universally, so it is not a mark against the clinic, but it does matter if the plan was to run treatment through a health plan.
Trust, oversight, and the honest caveat
LegitScript certification is in place. Serious telehealth pharmacies carry it, and operations that will not survive scrutiny generally cannot clear it. We found no FDA warning letters issued to the clinic, and what it discloses about its pricing and program is specific rather than vague. Now the caveat, which the clinic states itself in its FDA disclaimer. Compounded GLP-1s are not FDA-approved finished products in the way brand Ozempic or Zepbound are, and compounded semaglutide differs from the brand in formulation, concentration and dose ladder. Every compounded-telehealth provider lives with that, so it is not a failing unique to this one. It does mean that if an FDA-reviewed product is what you need, the brand-name access is the route to take rather than the compounded tiers.
Who it fits, and who it does not
- Choose it if you want the lowest-risk way to try a GLP-1, value being able to pick injectable or oral, and want coaching plus unlimited clinician access bundled in
- Choose it if LegitScript certification and a clinic willing to name its compounding pharmacies are what you are looking for
- Skip it if Louisiana is your state, insurance billing is a requirement, or nothing compounded will do and only FDA-approved brand medication counts
- Skip it if you want a flat price that never changes, the intro rates rise after the first plan term
Bottom line
He & She MD earns its spot for transparency and flexibility more than for any single price. Sitting below the $167 category median on its introductory tiers, it gives needle-averse and budget-conscious patients real choices, backs them with named pharmacies and LegitScript certification, and only charges you if you are actually prescribed. Go in clear about the introductory-then-standard pricing structure and the compounded-versus-brand distinction, and confirm your current rate at checkout before you commit. For a cash-pay GLP-1 starter, it is one of the more straightforward options out there. Our scoring methodology sets out the weighting behind all of this.
altRX ($89/month) and AgelessRx ($99/month) sit closest to He & She MD in what they charge and what they dispense.
The Bottom Line
He & She MD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on ease of signing up. Its compounded semaglutide costs $99 a month, paid up front, 50% below the $199 median among the sellers we compare.
Before you pay He & She MD
Starting at $99 a month. Check today's price, then start the intake.
Where He & She MD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
If none of these fits, our guide to alternatives to He & She MD sets more sellers in the same category beside He & She MD on price, states and what the price includes.
Frequently Asked Questions
How to check He & She MD yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
- How to Get a GLP-1 Prescription
Every seller that ships to your state, side by side: Arkansas, District of Columbia, Mississippi, Pennsylvania, Rhode Island, South Carolina, Washington, Wisconsin and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this He & She MD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See He & She MD's current pricing
Plans start at $99 a month. Whether you qualify is a clinician's decision, made after your intake.